Analyst consensus rating
MiniMed Group Analyst Rating: Buy
Direct answer
MiniMed Group's consensus rating is Buy.
15 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $25.33.
Forecast evidence checked November 14, 2026.
Get free MiniMed Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $17.99
- Average price target
- $25.33
- High price target
- $30.00
- Low price target
- $15.00
- Low target gap
- -16.6%
- Target upside
- +40.8%
- High target gap
- +66.8%
- Target range width
- 83.4%
- Consensus rating
- Buy
- Analysts
- 15
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for MiniMed Group?
MiniMed Group has a verified Buy consensus. The same dataset has an average price target of $25.33.
How far are MiniMed Group's low and high targets from the recorded price?
The low target implies -16.6%, while the high target implies +66.8%.
How many analysts are included in MiniMed Group's consensus?
The verified consensus includes 15 analysts.
How is MiniMed Group's target upside or downside calculated?
The average target of $25.33 is divided by the recorded price of $17.99, then one is subtracted to produce +40.8%. This does not guarantee a future return.
When was MiniMed Group's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.